Delivery Order SPE2DB20D7061-SPE2DB26FSLE9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging on August 18, 2025, with a ceiling value of $8,385.46. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order contains no set-aside designation, allowing full and open competition...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for Oseltamivir 75mg in unit dose packaging (10 units) valued at $6,188.16 under firm fixed-price terms. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,005.54 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg (10-count units) on November 7, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $2,129.64 and is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a $2,368.80 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 17, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,783.52 firm fixed-price delivery order is for the supply of 4,559,209,819 units of Oseltamivir Phosphate 75 mg capsules, a critical medication used for influenza treatment and prevention. The contract, awarded on November 29, 2022, has an ultimate completion date of November 30, 2022, indicating a short-term,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $6,534.13 and runs through March 19, 2025. It is a firm-fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,109.24 firm fixed-price contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, which are used to treat influenza. The award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB26FSLE9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) under a firm fixed-price contract with a ceiling value of $3,121.50. The order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded contract typical of the company's extensive federal pharmaceutical supply arrangements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies pharmaceutical products and medical supplies to support military healthcare systems and other government customers including the Defense Health Agency and U.S. Coast Guard. The Oseltamivir delivery supports the DLA's medical supply chain requirements for antiviral medications within the broader military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/10/25 |